30172 Federal Register / Vol. 76, No. 100 / Tuesday, May 24, 2011 / Notices 

EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN—Continued 

Interview type 

Maximum 

number of 

respondents 

Total burden 

hours 

Average 

hourly 

wage rate* 

Total cost 

burden 

Total .......................................................................................................... 120 147 NA 7,454

* The hourly wage for the participants across the four data collections (screening questionnaire, needs assessment interview, usability testing 

interviews, and discussion group interviews) is based upon the mean of the average hourly wages for Social science research assistants (19– 

4061; $19.39 per hour); Postsecondary Health Specialties Teachers (25–1071; $53.88 per hour);Management analysts (13–1111; $40.70 per 

hour); Computer and Information Systems Managers (11–3021; $58.00 per hour); Family and General Practitioners Teachers (29–1060; $81.03 

per hour);Pharmacists (29–1051; $51.27 per hour). May 2009 National Occupational Employment and Wage Estimates, United States, U.S. Bureau of Labor Statistics Division of Occupational Employment Statistics http://www.bls.gov/oes/current/oes_nat.htm#29–0000. 

Estimated Annual Costs to the Federal 

Government 

The estimated total cost to the Federal 

Government for this project is 

$411,641.00 over a two-year period from 

September 8, 2010 to September 7, 

2012. The estimated average annual cost 

is $205,821. 

Exhibit 3 provides a breakdown of the 

estimated total and average annual costs 

by category. 

EXHIBIT 3—ESTIMATED TOTAL AND ANNUAL COST * TO THE FEDERAL GOVERNMENT

Cost component Total cost Annualized 

cost 

Project Management and Coordination Activities ................................................................................................... $58,140 $29,070 

Evaluation Plan and Protocol Development ............................................................................................................ 44,908 22,454 

OMB Submission Package ...................................................................................................................................... 12,362 6,181 

Conduct Evaluation ** .............................................................................................................................................. 159,991 79,996 

Data Analysis, Report and Briefing ......................................................................................................................... 118,081 59,041 

Documentation and 508 Compliance ...................................................................................................................... 18,159 9,080 

Total .................................................................................................................................................................. 411,641 205,821 

* Costs are fully loaded including overhead, G&A and fees. 

** These activities include the data collections described in this submission. 

Request for Comments 

In accordance with the Paperwork 

Reduction Act, comments on AHRQ’s 

information collection are requested 

with regard to any of the following: (a) 

Whether the proposed collection of 

information is necessary for the proper 

performance of AHRQ healthcare 

research and healthcare information 

dissemination functions, including 

whether the information will have 

practical utility; (b) the accuracy of 

AHRQ’s estimate of burden (including 

hours and costs) of the proposed 

collection(s) of information; (c) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(d) ways to minimize the burden of the 

collection of information upon the 

respondents, including the use of 

automated collection techniques or 

other forms of information technology. 

Comments submitted in response to 

this notice will be summarized and 

included in the Agency’s subsequent 

request for OMB approval of the 

proposed information collection. All 

comments will become a matter of 

public record. 

Dated: May 10, 2011. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2011–12506 Filed 5–23–11; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Agency for Healthcare Research 

and Quality, HHS. 

ACTION: Notice. 

SUMMARY: This notice announces the 

intention of the Agency for Healthcare 

Research and Quality (AHRQ) to request 

that the Office of Management and 

Budget (OMB) approve the proposed 

information collection project: ‘‘Pilot 

Test of the Proposed Pharmacy Survey 

on Patient Safety Culture.’’ In 

accordance with the Paperwork 

Reduction Act, 44 U.S.C. 3501–3521, 

AHRQ invites the public to comment on 

this proposed information collection. 

This proposed information collection 

was previously published in the Federal 

Register on March 11th, 2011 and 

allowed 60 days for public comment. 

One comment was received. The 

purpose of this notice is to allow an 

additional 30 days for public comment. 

DATES: Comments on this notice must be 

received by June 23, 2011. 

ADDRESSES: Written comments should 

be submitted to: AHRQ’s OMB Desk 

Officer by fax at (202) 395–6974 

(attention: AHRQ’s desk officer) or by email at OIRA_submission@omb.eop.gov 

(attention: AHRQ’s desk officer). 

Copies of the proposed collection 

plans, data collection instruments, and 

specific details on the estimated burden 

can be obtained from the AHRQ Reports 

Clearance Officer. 

FOR FURTHER INFORMATION CONTACT: 

Doris Lefkowitz, AHRQ Reports 

Clearance Officer, (301) 427–1477, or by 

e-mail at doris.lefkowitz@

AHRQ.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Proposed Project 

Pilot Test of the Proposed Pharmacy 

Survey on Patient Safety Culture 

As the baby boomer population ages, 

the general U.S. population continues to 

grow, and as drug therapies for the 

treatment of chronic diseases become 

more efficacious, the expected increase 


jlentini on DSK4TPTVN1PROD with NOTICES
Federal Register / Vol. 76, No. 100 / Tuesday, May 24, 2011 / Notices 30173 

in the number of prescriptions and 

demand for pharmaceutical products is 

likely to increase the potential for 

medication errors in community/retail 

pharmacies. In 2007, there were about 

56,000 community/retail pharmacies, 

including about 22,000 traditional chain 

pharmacy companies, nearly 17,000 

independent drug stores, about 9,300 

supermarket pharmacies, and about 

7,700 mass merchant pharmacies. 

Numerous reports substantiate the 

presence of medication errors in 

pharmacies. For example, one national 

observational study of prescription 

dispensing accuracy and safety in 50 

pharmacies in the U.S. found a rate of 

about 4 errors per day in a pharmacy 

filling 250 prescriptions daily. This 

error rate translates to an estimated 51.5 

million errors occurring during the 

filling of 3 billion prescriptions each 

year. 

Given the widespread impact of 

pharmacies on patient safety, the new 

Pharmacy Survey on Patient Safety 

Culture (Pharmacy SOPS) will measure 

pharmacy staff perceptions about what 

is important in their organization and 

what attitudes and behaviors related to 

patient safety are supported, rewarded, 

and expected. The survey will help 

community/retail pharmacies to identify 

and discuss strengths and weaknesses of 

patient safety culture within their 

individual pharmacies. They can then 

use that knowledge to develop 

appropriate action plans to improve 

their practices and their culture of 

patient safety. This survey is designed 

for use in community/retail pharmacies, 

which includes chain drugstores (e.g., 

Walgreens and CVS), supermarket 

pharmacies, independently owned 

pharmacies, and mass merchant 

pharmacies (e.g., Wal-Mart, Costco, 

Target), not for use in hospital 

pharmacies. 

This research has the following goals: 

(1) Cognitively test and modify as 

necessary the Pharmacy Survey on 

Patient Safety Culture Questionnaire; 

(2) Pretest and modify the 

questionnaire as necessary; 

(3) Make the final questionnaire 

available to the public. 

This study is being conducted by 

AHRQ through its contractor, Westat, 

pursuant to AHRQ’s statutory authority 

to conduct and support research on 

healthcare and on systems for the 

delivery of such care, including 

activities with respect to the quality, 

effectiveness, efficiency, 

appropriateness and value of healthcare 

services and with respect to quality 

measurement and improvement. 

42 U.S.C. 299a(a)(1) and (2). 

Method of Collection 

To achieve the goals of this study the 

following activities and data collections 

will be implemented: 

(1) Cognitive interviews—Two rounds 

of interviews will be conducted by 

telephone with 10 respondents each. 

The purpose of these interviews is to 

refine the questionnaire’s items and 

composites. Each round will be 

conducted with a mix of pharmacists 

and non-pharmacist staff working in 

community/retail pharmacies 

throughout the U.S. The same interview 

guide will be used for each round. 

(2) Pretest—The draft questionnaire 

will be pretested with all pharmacy staff 

in approximately 60 community/retail 

pharmacies. The purpose of the pretest 

is to collect data for an assessment of 

the reliability and construct validity of 

the survey’s items and composites, 

allowing for their further refinement. 

(3) Pharmacy background 

questionnaire—This questionnaire will 

be completed by the pharmacy manager 

in each of the 60 pretest sites to provide 

background characteristics of the 

pharmacy, such as pharmacy type 

(independently owned or chain), type of 

chain (traditional drugstore, 

supermarkets, mass merchant), average 

number of prescriptions filled weekly, 

average number of hours the pharmacy 

is open on weekdays, etc. 

(4) Dissemination activities—The 

final questionnaire will be made 

available to the public through the 

AHRQ website. This activity does not 

impose a burden on the public and is 

therefore not included in the burden 

estimates in Exhibit 1. 

The information collected will be 

used to test and improve the draft 

survey items in the Pharmacy Survey on 

Patient Safety Culture Questionnaire. 

Psychometric analysis will be 

conducted on the pilot data to examine 

item nonresponse, item response 

variability, factor structure, reliability, 

and construct validity of the items 

included in the survey. Because the 

survey items are being developed to 

measure specific aspects of patient 

safety culture in the pharmacy setting, 

the factor structure of the survey items 

will be evaluated through multilevel 

confirmatory factor analysis. On the 

basis of the data analyses, items or 

factors may be dropped. 

Estimated Annual Respondent Burden 

Exhibit 1 shows the estimated 

annualized burden hours for the 

pharmacies’ time to participate in this 

research. Cognitive interviews will be 

conducted with staff at 20 pharmacies 

(approximately 10 pharmacists and 10 

nonpharmacist staff) and will take about 

one hour and 30 minutes to complete. 

627 staff from 60 pharmacies will 

participate in the pretest (an average of 

10.45 staff from each pharmacy). The 

pretest questionnaire (the Pharmacy 

Survey on Patient Safety Culture) 

requires 15 minutes to complete. The 

pharmacy background questionnaire 

will be completed by the manager at 

each of the 60 pharmacies participating 

in the pretest and takes 10 minutes to 

complete. The total annualized burden 

is estimated to be 197 hours. 

Exhibit 2 shows the estimated 

annualized cost burden associated with 

the pharmacies’ time to participate in 

this research. The total cost burden is 

estimated to be $4,948 annually. 

EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS

Form Name/activity Number of 

pharmacies 

Number of 

responses 

per pharmacy 

Hours per 

response 

Total burden 

hours 

Cognitive interviews ......................................................................................... 20 1 1.5 30 

Pretest .............................................................................................................. 60 10.45 15/60 157 

Pharmacy background questionnaire .............................................................. 60 1 10/60 10 

Total .......................................................................................................... 140 na na 197 


jlentini on DSK4TPTVN1PROD with NOTICES
30174 Federal Register / Vol. 76, No. 100 / Tuesday, May 24, 2011 / Notices 

EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN

Form Name/activity Number of 

pharmacies 

Total burden 

hours 

Average 

hourly wage 

rate * 

Total cost 

burden 

Cognitive interviews ......................................................................................... 20 30 $32.28 $968 

Pretest .............................................................................................................. 60 157 22.08 3,467 

Pharmacy background questionnaire .............................................................. 60 10 51.27 513 

Total .......................................................................................................... 140 197 na $4,948 

* Based upon the mean of the average hourly wages for Pharmacists (29–1051; $51.27), Pharmacy Technicians (29–2052; $13.92), and Pharmacy Aides (31–9095; $10.74), National Compensation Survey: Occupational wages in the United States May 2009, ‘‘U.S. Department of Labor, 

Bureau of Labor Statistics.’’ The hourly wage for the cognitive interviews is a weighted average for 10 pharmacists, 8 pharmacy technicians and 

2 pharmacy aides; the hourly wage for the pretest is a weighted average for 157 pharmacists, 235 pharmacy technicians and 235 pharmacy 

aides. 

Estimated Annual Costs to the Federal 

Government 

Exhibit 3 shows the estimated total 

and annualized cost for this project. 

Although data collection will last for 

less than one year, the entire project 

will take about 3 years. The total cost for 

this project is approximately $320,818. 

EXHIBIT 3—ESTIMATED TOTAL AND ANNUALIZED COST

Cost component Total cost Annualized 

cost 

Project Development ............................................................................................................................................... $65,340 $21,780 

Data Collection Activities ......................................................................................................................................... 62,831 20,944 

Data Processing and Analysis ................................................................................................................................. 11,004 3,368 

Publication of Results .............................................................................................................................................. 15,767 5,256 

Project Management ................................................................................................................................................ 7,496 2,498 

Overhead ................................................................................................................................................................. 158,380 5,293 

Total .................................................................................................................................................................. 320,818 106,939 

Request for Comments 

In accordance with the Paperwork 

Reduction Act, comments on AHRQ’s 

information collection are requested 

with regard to any of the following: 0(a) 

Whether the proposed collection of 

information is necessary for the proper 

performance of AHRQ healthcare 

research and healthcare information 

dissemination functions, including 

whether the information will have 

practical utility; (b) the accuracy of 

AHRQ’s estimate of burden (including 

hours and costs) of the proposed 

collection(s) of information; (c) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(d) ways to minimize the burden of the 

collection of information upon the 

respondents, including the use of 

automated collection techniques or 

other forms of information technology. 

Comments submitted in response to 

this notice will be summarized and 

included in the Agency’s subsequent 

request for OMB approval of the 

proposed information collection. All 

comments will become a matter of 

public record. 

Dated: May 10, 2011. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2011–12505 Filed 5–23–11; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Interagency Committee on Smoking 

and Health: Notice of Charter Renewal 

This gives notice under the Federal 

Advisory Committee Act (Pub. L. 92– 

463) of October 6, 1972, that the 

Interagency Committee on Smoking and 

Health, Department of Health and 

Human Services, has been renewed for 

a 2-year period through March 20, 2013. 

For information, contact Dana 

Shelton, Designated Federal Officer, 

Interagency Committee on Smoking and 

Health, Centers for Disease Control and 

Prevention, Department of Health and 

Human Services, 1600 Clifton Road, 

M/S K–50, Atlanta, Georgia 30333, 

telephone 770/488–5709 or fax 770/ 

488–5767. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: April 11, 2011. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2011–12568 Filed 5–23–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Statement of Organization, Functions, 

and Delegations of Authority 

Part C (Centers for Disease Control 

and Prevention) of the Statement of 

Organization, Functions, and 

Delegations of Authority of the 

Department of Health and Human 

Services (45 FR 67772–76, dated 


jlentini on DSK4TPTVN1PROD with NOTICES